Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $8,000/year · Income ≤500% FPL · Covers drug cost only — administration billed separately
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C82.0 C82.1 C82.9 C83.0 C83.3 C83.5 C83.8 C85.1 C85.9 C91.1Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J9268
The foundation's own covered-medication list for this fund (252 drugs). Confirm coverage of your exact NDC at application.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 800-675-8416, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Columvi, Gazyva, Rituxan / biosimilars, Lunsumio.
Status shown as of each fund's last verification.
As of June 11, 2026, the HealthWell Foundation B-Cell Lymphoma (Medicare Access) fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 800-675-8416.
Up to $8,000/year. Covers drug cost only — administration billed separately
Household income must be ≤500% FPL. US resident.
Accepted: commercial, medicare. Not eligible: medicaid.
The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.